Buspirone for Weak or Absent Esophageal Peristalsis
Status:
Recruiting
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, cross-over clinical trial of
buspirone in patients with complaints of dysphagia due to poor esophageal motility. The goal
of this clinical trial is to study the effect of buspirone on esophageal motility by
performing high resolution impedance manometry (HRiM).